Healthcare Service Provider
Key highlights
- Diagnostics remains a structurally attractive healthcare service provider segment, supported by preventive testing, chronic-disease screening, home collection and specialty diagnostics demand.
- Thyrocare Technologies delivered Q2 FY27 consolidated revenue growth of 25.1% YoY to ₹270.8 Cr, while EBITDA rose 24.9% YoY to ₹89.3 Cr with a 33.0% margin.
- Thyrocare’s pathology business remains the core growth engine, with Q2 FY27 pathology revenue up 25.7% YoY to ₹257.2 Cr; radiology revenue declined 4.3% YoY to ₹13.6 Cr following exits from non-profitable centres.
- Credent Connect N Care reported H1 FY27 revenue growth of 53% YoY to ₹138.1 Cr and EBITDA growth of 53% YoY to ₹18.2 Cr, although operating cash flow remained negative at ₹3.9 Cr.
- Organised healthcare providers benefit from rising chronic diseases, insurance penetration, increasing preventive healthcare spending, higher diagnostic intensity and expansion into Tier-II and Tier-III cities.
- Key sector risks include pricing pressure, talent costs, regulatory compliance, working-capital intensity, technology obsolescence, quality failures and capital-allocation risks from acquisitions or network expansion.
powered by IRIS
Unlock full access to this sectoral analysis with in-depth insights, comprehensive data, and exclusive reports.


